Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger? -- Ignore unavailable to you. Want to Upgrade?

To: Rich C who wrote (154)	8/12/1999 5:01:00 PM
From: jsavage	Respond to of 315

Well this certainly shouldn't hurt.... BlueStone Capital Partners Announces Investment Opinion on Candela Corporation Business Wire - August 12, 1999 14:25 NEW YORK--(BUSINESS WIRE)--Aug. 12, 1999-- BlueStone Capital Partners, L.P. Re-iterates STRONG BUY Rating on CLZR Senior Analyst Scott Baily at Bluestone Capital reiterates his STRONG BUY recommendation on Candela Corporation (NASDAQ: CLZR $14 1/2) following its secondary stock offering, with a 12-18 month price target of $20-$25. Analyst's Summary Since the recent closing of CLZR's secondary common stock offering of 2.43 million shares, the company raised approximately $20 million in proceeds, net of expenses. Total common stock outstanding after the secondary is 8.1 million shares. Because the offering was completed after the closing of FY99 (June), or FY99 EPS estimate remains unchanged at $1.05, up from an operating EPS loss of $0.33 per share in FY98. However, following CLZR's dilution from an offering of 2.4 million shares, our new FY00 EPS estimate is $1.10, revised down from our previous EPS estimate of $1.30. We are also initiating FY01 and FY02 EPS estimates of $1.35 and $1.60, respectively. With CLZR's stock currently selling for 12.7 and 10.4 times our revised FY00 and new FY01 (June) EPS estimates of $1.10 and $1.35, we still view the stock as quite attractive at current price levels given our outlook for the company. With CLZR's stock selling at $14, the stock is trading at an attractive discount to our annual growth rate expectations. If CLZR's stock traded at a P/E valuation of 15x-20x our estimates, which is equal to our revenue growth rate projections of 15%-20%, we believe the stock's upside based on our FY00 and FY01 EPS estimates of $1.10 and $1.35 is realistically in the range of $20-$25. This represents a potential gain of 42%-78%. We continue to rate CLZR's stock a STRONG BUY. BlueStone Capital Partners, L.P. is a full service investment banking and brokerage firm that delivers financial services to emerging growth and medium size companies worldwide. BlueStone Capital assists Clients in maximizing their growth by providing sophisticated investment strategies that are designed to achieve clients strategic, operating and financial goals. CONTACT: BlueStone Capital Scott A. Baily 212/850-0558 I just hope it helps.